0001437749-21-022776.txt : 20210928 0001437749-21-022776.hdr.sgml : 20210928 20210928162629 ACCESSION NUMBER: 0001437749-21-022776 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210927 FILED AS OF DATE: 20210928 DATE AS OF CHANGE: 20210928 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Berger Mark Stanley CENTRAL INDEX KEY: 0001700283 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38244 FILM NUMBER: 211287221 MAIL ADDRESS: STREET 1: 140 RIVERSIDE DRIVE STREET 2: APT. 9K CITY: NEW YORK STATE: NY ZIP: 10024 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Genprex, Inc. CENTRAL INDEX KEY: 0001595248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900772347 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1601 TRINITY STREET, BLDG. B STREET 2: SUITE 3.322 CITY: AUSTIN STATE: TX ZIP: 78712 BUSINESS PHONE: 512-537-7997 MAIL ADDRESS: STREET 1: 1601 TRINITY STREET, BLDG. B STREET 2: SUITE 3.322 CITY: AUSTIN STATE: TX ZIP: 78712 4 1 rdgdoc.xml FORM 4 X0306 4 2021-09-27 0001595248 Genprex, Inc. GNPX 0001700283 Berger Mark Stanley 3300 BEE CAVE ROAD #650-227 AUSTIN TX 78746 1 Chief Medical Officer Stock Option (right to buy) 2.85 2021-09-27 4 A 0 550000 0 A 2022-09-27 2031-09-27 Common Stock 550000 550000 D The options were granted outside of the Registrant's incentive award plans as an inducement grant pursuant to Nasdaq Listing Rule 5635(c)(4). One-third of the options will vest on each of the first, second and third anniversaries of the date on which the Reporting Person commences employment with the Registrant. /s/ Ryan Confer as Attorney-In-Fact for Mark S. Berger 2021-09-28